Trial Profile
Phase II investigator-sponsored trial of single-agent palifosfamide in patients with recurrent metastatic germ cell cancer who have relapsed after initial platinum-based therapy and high-dose chemotherapy.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2022
Price :
$35
*
At a glance
- Drugs Palifosfamide (Primary)
- Indications Germ cell cancer; Ovarian cancer; Testicular cancer
- Focus Therapeutic Use
- 11 Mar 2013 New trial record